Header Logo

Connection

Katie Kompoliti to Middle Aged

Back to Details
This is a "connection" page, showing publications Katie Kompoliti has written about Middle Aged.
Katie Kompoliti
Connection Strength
0.360
Middle Aged
  1. Multidisciplinary inpatient rehabilitation for Functional Movement Disorders: A prospective study with long term follow up. Parkinsonism Relat Disord. 2021 01; 82:50-55.
    View in: PubMed
    Score: 0.070
  2. Clinical Features of Tourette Syndrome. J Child Neurol. 2020 02; 35(2):166-174.
    View in: PubMed
    Score: 0.064
  3. Impact of placebo assignment in clinical trials of tic disorders. Mov Disord. 2013 Aug; 28(9):1288-92.
    View in: PubMed
    Score: 0.041
  4. Association between antipsychotics and body mass index when treating patients with tics. J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):277-81.
    View in: PubMed
    Score: 0.034
  5. Complementary and alternative medicine use in Gilles de la Tourette syndrome. Mov Disord. 2009 Oct 15; 24(13):2015-9.
    View in: PubMed
    Score: 0.032
  6. Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient. Mov Disord. 2007 Aug 15; 22(11):1630-3.
    View in: PubMed
    Score: 0.028
  7. "On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord. 2000 Mar; 15(2):309-12.
    View in: PubMed
    Score: 0.017
  8. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology. 2000 Jan 25; 54(2):458-62.
    View in: PubMed
    Score: 0.016
  9. Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998 Aug; 55(8):1099-102.
    View in: PubMed
    Score: 0.015
  10. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014 May; 71(5):543-52.
    View in: PubMed
    Score: 0.011
  11. Camptocormia associated with focal myositis in multiple-system atrophy. Mov Disord. 2006 Mar; 21(3):390-4.
    View in: PubMed
    Score: 0.006
  12. Nurr1 in Parkinson's disease and related disorders. J Comp Neurol. 2006 Jan 20; 494(3):495-514.
    View in: PubMed
    Score: 0.006
  13. Dopaminergic hypersensitivity in patients with Parkinson disease and migraine. Clin Neuropharmacol. 2004 Jan-Feb; 27(1):30-2.
    View in: PubMed
    Score: 0.005
  14. The importance of educational and psychological factors in Parkinson's disease quality of life. Eur J Neurol. 2002 Nov; 9(6):589-93.
    View in: PubMed
    Score: 0.005
  15. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002 Oct; 59(10):1541-50.
    View in: PubMed
    Score: 0.005
  16. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J Comp Neurol. 2002 Aug 26; 450(3):203-14.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.